MedPath

Using EMR Data and AI to Develop a Passive Digital Marker to Predict Postoperative Delirium

Not Applicable
Recruiting
Conditions
Delirium in Old Age
Interventions
Other: PDM Alert
Registration Number
NCT06216483
Lead Sponsor
Indiana University
Brief Summary

This study will be a pilot randomized controlled trial that will determine the effect of an indicator of delirium risk, which will be delivered either via a paper form or via the electronic medical record, on (1)postoperative delirium incidence; and (2)the development of long term cognitive decline and dementia.

Detailed Description

Patients will be recruited from a large general, minimally invasive, colorectal, and oncologic, university-based surgical practice. English speaking individuals over the age of 65 with planned major abdominal surgery (encompassing abdominal wall, gastrointestinal and hepatobiliary procedures for benign and malignant diseases) will be screened for eligibility following an initial visit with their surgeon. Inclusion criteria will include a required inpatient stay for ≥ 24 hours following surgery and a scheduled preadmission testing and medical risk stratification visit with an internal medicine provider. Patients will be excluded if they have severe mental illness, hearing and visual impairment, alcohol intoxication or related delirium, central nervous disorder (e.g., stroke, traumatic brain injury), and pregnant or nursing status. Once enrolled, subjects will be randomized using a computer-generated scheme (permuted blocks of four and six) to the PDM or usual care, stratified according to type of surgery (hepatobiliary, gastrointestinal, abdominal wall).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

65 years old Planned inpatient major surgery requiring inpatient stay ≥ 1 day

Exclusion Criteria
  • Baseline cognitive impairment or a diagnosis of Alzheimer's Disease/Alzheimer's Disease and Related Dementias (AD/ADRD)
  • Alcohol or drug withdrawal
  • Prisoner status
  • Unable to communicate with research staff due to sensory impairments
  • Not fluent in English
  • Currently has a personal safety attendant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PDM AlertPDM AlertPDM alert will be placed on subject's record
No PDM AlertPDM AlertNo PDM alert will be placed on subject's record
Primary Outcome Measures
NameTimeMethod
Delirium incidence as measured by the 3D-CAMDaily during post-operative inpatient hospitalization through post-operative day 7

The number of subjects diagnosed with delirium via the 3D-CAM questionnaire will be measured. The 3D-CAM is a brief verbal assessment tool that can be used to test patients and study participants for delirium via the Confusion Assessment Method (CAM). The 3D-CAM assessment is scored as either delirium present or delirium not present. Participants will be evaluated daily during the acute post-operative phase of the study (Post-Operative Days 0-7).

Delirium incidence as measured by the CAM ICUDaily during post-operative inpatient hospitalization through post-operative day 7

The number of subjects diagnosed with delirium as assessed by the Confusion Assessment Method ICU will be measured. The CAM ICU is a tool used to assess delirium in adult ICU patients. CAM ICU scoring ranges from 0-7 with scores between 0-2 indicating no delirium, between 3-5 indicating mild to moderate delirium, and between 6-7 indicating severe delirium. Participants will be evaluated daily during the acute post-operative phase of the study (Post-Operative Days 0-7).

Delirium severity as measured by the CAM ICUDaily during post-operative inpatient hospitalization through post-operative day 7

Delirium severity will be assessed via the Confusion Assessment Method ICU, a tool used to assess delirium in adult ICU patients. The CAM ICU is a tool used to assess delirium in adult ICU patients. CAM ICU scoring ranges from 0-7 with scores between 0-2 indicating no delirium, between 3-5 indicating mild to moderate delirium, and between 6-7 indicating severe delirium. Participants will be evaluated daily during the acute post-operative phase of the study (Post-Operative Days 0-7).

Secondary Outcome Measures
NameTimeMethod
Inpatient fallsDuring post-operative inpatient hospitalization through post-operative day 7

The number of inpatient falls will be compared between groups. This data will be extracted from the participants' Electronic Medical Record.

Restraint UseDuring post-operative inpatient hospitalization through post-operative day 7

Use of restraints will be compared between groups. This data will be extracted from the participants' Electronic Medical Record.

Sedative UseDuring post-operative inpatient hospitalization through post-operative day 7

Sedative use will be compared between groups. This data will be extracted from the participants' Electronic Medical Record.

Use of personal safety attendantsDuring post-operative inpatient hospitalization through post-operative day 7

Personal safety attendant use will be compared between groups. This data will be extracted from the participants' Electronic Medical Record.

Provider SatisfactionWithin 2-6 weeks following participant discharge

Provider satisfaction will be measured determined by a Simplified System Usability Scale (SSUS). The SSUS will be administered to providers within two weeks of the participant's discharge from the hospital, and providers will be asked to respond within 4 weeks of survey receipt. The SSUS yields a single number representing a composite measure of the overall usability of the system. Scores can range from 0 to 100, with higher scores indicating better usability.

Trial Locations

Locations (1)

Indiana University Health University Hospital

🇺🇸

Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath